Voices Against Brain Cancer Discusses New Approach for Studying Deadly Brain Cancer
Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new approach for studying glioblastoma multiforme, one of the most common and aggressive forms of brain cancer.
New York, NY (PRWEB) July 29, 2013
On July 29, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new approach for studying human glioblastoma multiforme, one of the most common and aggressive forms of brain cancer.
According to a July 23, 2013 article published on ScienceDaily.com entitled “New Approach for Studying Deadly Brain Cancer,” human glioblastoma multiforme, one of the most common and aggressive forms of brain cancer, has been extremely difficult to study. Traditionally, scientists have studied cancer cells in petri dishes, “which have none of the properties of the brain tissues in which these cancers grow.”
A team of engineers has developed a three-dimensional hydrogel that “closely mimics conditions in the brain.” According to researchers, this hydrogel is more versatile than other 3-D gels used for growing glioma cells because it allows researchers to change “individual traits” like the gel’s stiffness while minimally altering its other characters. The ability to adjust these parameters individually will enable researchers to “tease out important features associated with the initial growth of a tumor as well as its response to clinical therapies.”
Michael Klipper, Chairman of Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, is optimistic about this new method. “It’s comforting to hear about all the progress in brain cancer research being made by today’s scientists and researchers. It gives those who are battling this horrible disease hope that there will be a future cure.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10960534.htm